StonvexLoading…
StonvexStonvexStonvexCore line items from CNP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $9.34B | $8.55B | $8.61B | $9.33B |
Operating Income | $2.11B | $1.99B | $1.76B | $1.57B |
Net Income | $1.05B | $1.02B | $917.00M | $1.06B |
EPS (Diluted) | $1.60 | $1.58 | $1.37 | $1.59 |
Total Assets | $46.53B | $43.77B | $39.72B | $38.55B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $38.00M | $24.00M | $90.00M | $74.00M |
Free Cash Flow OCF − CapEx | $-2.38B | $-2.37B | $-524.00M | $-2.61B |
Shares Outstanding | 652.87M | 651.73M | 631.23M | 629.54M |